Telo Genomics Corp.
Pagina dedicata companiei Telo Genomics Corp. listata cu simbolul CA.TELO
Descriere companie[edit | ]
Telo Genomics Corp. (https://www.telodx.com/) is a Canada-based biotech company. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for numerous diseases that display genomic instability. Its lead application, Telo-MM is being developed to provide information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. The Company's TeloView software consists of two parts, analytical software and a corresponding report designed for clinical decision making. TeloView utilizes the three-dimensional analysis of approximately six parameters generated from the telomeres of a single cell. Its TeloView software generates a report for the clinician that contains information, including the stage of a given disease, its rate of progression and how it responds to therapy. Its solutions include liquid biopsies and related technologies in oncology and neurological diseases.
Grafic actiuni companie[edit | ]